Bhuvaneswari Ramaswamy
Biochemistry, Genetics and Molecular Biology · The Ohio State University
Publications
287
Citations
7,400
Est. group size
~59
Recurring co-author estimate
Active years
24
Publishing since 2003
This researcher's work centers on breast cancer, including clinical trials of targeted therapies, endocrine and immune-based treatments, and laboratory studies of mammary gland biology and drug resistance mechanisms. The publication record also includes broader oncology topics such as photodynamic therapy for head and neck cancers, tumor lysis syndrome, and cancer health disparities, often as part of large multi-author clinical and translational research teams. Note that two 2025 titles on quantum computing appear unrelated to this profile and may reflect a data or author-matching error.
Publication output grew steadily from 2017 to a peak around 2020-2023, then declined notably in 2024-2025.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- 47119 Quantum AI for Decision-Making: Revolutionizing Intelligent Systems
2025
- 28912 Enhancing Quantum-Safe UAV Navigation and Collision Avoidance
2025
- Efficacy and safety of pembrolizumab in advanced neuroendocrine tumors (NETs): A meta-analysis of clinical trials.
JCO Global Oncology · 2023
- Tumor lysis syndrome in solid tumors: A retrospective cohort study of the National Inpatient Sample from 2016 to 2019.
Journal of Clinical Oncology · 2023
- 1456 Colorectal cancer disparities: a systematic review
Regular and Young Investigator Award Abstracts · 2023
- Abstract 2561: Computational drug repositioning identifies Akt inhibitor MK2206 binding to EZH2 as enhancer of Tazmetostat efficacy in inhibition of triple negative breast cancer proliferation
Cancer Research · 2023
- Breast cancer disparities: A literature review of the last five years.
Journal of Clinical Oncology · 2023
- Immune checkpoint inhibitors therapy in advanced bladder carcinoma: A meta-analysis of phase III randomized controlled trials.
Journal of Clinical Oncology · 2023
- An analysis of Plan, Do, Study, Act for a supportive care program for patients with metastatic breast cancer.
JCO Oncology Practice · 2023
- Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer
Annals of Oncology · 2022
- Abstract PS17-28: Abrupt involution of lactating mammary gland induces metabolic reprogramming conducive to pro-tumorigenic changes
Cancer Research · 2021
- Abstract P5-07-11: Mammary gland specific Stat3 deletion during involution results in distinct histological changes and higher collagen deposition
Cancer Research · 2020
- Abstract P1-18-22: Unlocking Her2 as a target in invasive lobular cancer and endocrine resistant invasive ductal carcinoma
Cancer Research · 2020
- Breastfeeding to Reduce Breast cancer Risk, Especially in African-American Women
2020
- The Hedgehog Signaling Pathway: A Viable Target in Breast Cancer?
Cancers · 2019
- Cancer Research×40
- Journal of Clinical Oncology×28
- Breast Cancer Research and Treatment×7
- Research Square×6
- Frontiers in Oncology×4
- Mathew Cherian
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Julie Stephens
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Nicole Williams
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- JY Kim
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Marilly Palettas
Biochemistry, Genetics and Molecular Biology · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile